PLoS ONE (Jan 2017)

snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma.

  • Natasha Andressa Nogueira Jorge,
  • Gabriel Wajnberg,
  • Carlos Gil Ferreira,
  • Benilton de Sa Carvalho,
  • Fabio Passetti

DOI
https://doi.org/10.1371/journal.pone.0183410
Journal volume & issue
Vol. 12, no. 8
p. e0183410

Abstract

Read online

Lung cancer is one of the most frequent types of cancer worldwide. Most patients are diagnosed at advanced stage and thus have poor prognosis. Smoking is a risk factor for lung cancer, however most smokers do not develop lung cancer while 20% of women with lung adenocarcinoma are non-smokers. Therefore, it is possible that these two groups present differences besides the smoking status, including differences in their gene expression signature. The altered expression patterns of non-coding RNAs in complex diseases make them potential biomarkers for diagnosis and treatment. We analyzed data from differentially and constitutively expressed PIWI-interacting RNAs and small nucleolar RNAs from publicly available small RNA high-throughput sequencing data in search of an expression pattern of non-coding RNA that could differentiate these two groups. Here, we report two sets of differentially expressed small non-coding RNAs identified in normal and tumoral tissues of women with lung adenocarcinoma, that discriminate between smokers and non-smokers. Our findings may offer new insights on metabolic alterations caused by tobacco and may be used for early diagnosis of lung cancer.